Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, reflecting a maintenance update to the page's software version. No study content, data, or results were modified.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 removed. This is a site version update that does not modify study content or user actions.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision tag on the page updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice along with Revision: v3.4.1 were removed; this appears to be a site-wide administrative update rather than a change to study information.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.